Equities Analysts Set Expectations for ACRV FY2025 Earnings
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of Acrivon Therapeutics in a report released on Thursday, May 15th. Cantor Fitzgerald analyst L. Watsek now anticipates that the company will post earnings per share of ($1.97) for the year, down […]
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of Acrivon Therapeutics in a report released on Thursday, May 15th. Cantor Fitzgerald analyst L. Watsek now anticipates that the company will post earnings per share of ($1.97) for the year, down […]
